Is this an established Boston Terrier condition?
No. It is documented in specific research lines of other breeds, and appears on some panels as part of broad, non-breed-specific screening.
Quick answer
Is this an established Boston Terrier condition?
No. It is documented in specific research lines of other breeds, and appears on some panels as part of broad, non-breed-specific screening.
Seeing a rare, frightening disease name attached to a DNA report is unsettling regardless of the actual odds. Understanding what the test was built for puts the fear in proportion.

Owners who ran a broad genetic panel out of curiosity and found an unfamiliar, alarming-sounding result, and anyone trying to work out why a condition documented in different breeds appears on their own dog's report at all.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
We research and check what we publish, but we do not warrant that any figure, date, price, or statement is accurate, complete, or current, and we accept no liability for any loss, cost, injury, or other harm arising from the use of this site. Use it as one reference among several. You remain responsible for your own decisions and for your dog's care - confirm anything that matters with a licensed veterinarian or another qualified professional before you act on it. Full disclaimer.
X-linked severe combined immunodeficiency is a severe, typically fatal inherited immune disorder, well characterised in specific research lines of Basset Hounds and Cardigan Welsh Corgis. It has not been documented as occurring in Boston Terriers, and its presence on a genetic panel result usually reflects broad, non-breed-specific screening design rather than an established risk in this breed. Understanding the disease and why it appears on a report matters more here than treating the result as a genuine breed-specific concern.
Not documented as occurring in Boston Terriers. The disease itself is exceptionally rare even in the specific breeds and research lines where it has been characterised, and its relevance to this breed is limited to occasionally appearing as one line on a broad genetic screening report.
There is no established breed-specific driver in Boston Terriers, and it would be misleading to describe one. The gene involved exists across dogs generally, which is why some panels test broadly for it, but the mutations characterised as disease-causing were identified and studied in specific research lines of other breeds entirely.
Environment plays no meaningful role in this specific inherited mutation. What the environment does influence, for any young puppy regardless of genetic cause, is how quickly a genuine immune weakness would become apparent - exposure to infectious agents at a young age reveals a compromised immune system faster than a sheltered early life would.
Bring any panel result you do not understand to a routine appointment so it can be explained in the context of this specific breed. There is no emergency tied to this particular test result in a Boston Terrier; treat as urgent, regardless of genetics, any young puppy with repeated severe infections, failure to thrive, or a poor response to normal veterinary care, since those signs warrant prompt investigation on their own merits.
See all Boston Terrier health problems, which breeds are prone to x scid, or the full Boston Terrier breed guide for temperament, exercise needs and ownership costs.
There is no timeline to manage here for a Boston Terrier, since the disease is not an established condition in this breed. The only relevant timeline is however long it takes to get a confusing panel result properly explained, which is typically resolved in a single conversation with your vet.
An owner who understands why a rare, severe-sounding result appeared on a broad panel, has filed it away appropriately, and continues focusing preventive care on the conditions genuinely documented in this breed rather than on a line item borrowed from a different breed's research history.
X-linked severe combined immunodeficiency is caused by a mutation in a gene, carried on the X chromosome, that is essential for building functional T cells and natural killer cells - core parts of the immune system's ability to fight infection. Affected puppies are born without a working adaptive immune system. They typically appear normal at birth, then develop repeated, severe infections within the first weeks to months of life as maternal antibodies wear off, and without extraordinary intervention such as a bone marrow transplant the condition is fatal in early puppyhood.
Because the mutation sits on the X chromosome, it follows a specific inheritance pattern: males need only one copy to be affected, while females need two, which is part of why research colonies used to study it were able to trace it so precisely. That precision is exactly why it is documented in specific lines of Basset Hounds and Cardigan Welsh Corgis rather than described as a general risk across dog breeds - it was found, characterised and mapped in those particular research populations.
Boston Terriers are not one of the breeds in which this disease has been documented as naturally occurring. Some broad genetic panels test for it regardless of breed, either because the underlying gene is shared across all dogs or as a standard inclusion in a wide screening product, and a clear result for a Boston Terrier reflects that broad, non-breed-specific screening rather than any established risk in this breed.

A few principles help when a panel flags something this unfamiliar and this severe-sounding.
Adaeze ran a comprehensive genetic panel on her Boston Terrier puppy, Bramble, mostly out of general interest before his first vaccinations. Scrolling through fifty results, one line stopped her cold: X-linked severe combined immunodeficiency, clear. She had never heard of the disease and spent an anxious hour reading about puppies dying of infections in the first weeks of life before she thought to actually read the rest of the report, which noted the variant had been characterised in specific research colonies of other breeds entirely. At Bramble's next vaccination visit, her vet confirmed that this was not a condition documented in Boston Terriers, and that broad panels commonly test across a standard list regardless of breed relevance. Bramble's result, in any case, was clear - he did not carry the mutation at all. Adaeze kept the full report, but she stopped reading disease names in isolation after that, and now looks specifically at what a panel says about breed validation before letting any single line worry her.
Key takeaway: A rare, alarming name on a broad panel is not the same as a breed-relevant risk. Read what the report says about validation before letting one line rewrite how you feel about a healthy puppy.
It has not been documented as occurring in this breed. It is characterised in specific research lines of Basset Hounds and Cardigan Welsh Corgis, and its appearance on a broad panel reflects wide screening design rather than an established Boston Terrier risk.
Many commercial panels screen for the same list of conditions across many or all breeds submitted, partly because the underlying genes exist in every dog and partly as a matter of product design, rather than tailoring the list strictly to documented breed risk.
Affected puppies appear normal at birth, then develop repeated, severe infections within the first weeks to months of life as maternal immunity wears off, and the condition is typically fatal in early puppyhood without extraordinary treatment.
Through the X chromosome. Males need only one copy of the mutation to be affected; females need two, which is why males are more often clinically affected in the research populations where this has been studied.
It is a reasonable question for any genetic result you do not understand, but there is no established basis for asking Boston Terrier breeders to screen for this particular disease the way you would for conditions actually documented in the breed.
A young puppy with repeated, severe infections that do not respond normally to treatment, failure to thrive, or a poor response to normal care is always worth prompt veterinary attention, regardless of the underlying cause, immune-related or otherwise.
Not as a documented pattern. If you have specific information about a bloodline, that is worth discussing directly with your vet and, if relevant, the breeder, rather than assuming it applies broadly to the breed.
No. It is documented in specific research lines of other breeds, and appears on some panels as part of broad, non-breed-specific screening.
That your dog does not carry the specific tested mutation - useful information, even though the disease itself is not an established risk in this breed.
Not a priority for a Boston Terrier specifically; it is usually included as part of a broad panel rather than purchased on its own.
Repeated or unusually severe infections and poor growth are worth a vet visit regardless of the underlying cause - that general vigilance matters more than one rare named test.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





